Biolase Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview

November 26

11/05/2021 21:34

* BIOLASE Inc  BIOL.OQ   BIOL.O  is expected to show a rise in
quarterly revenue when it reports results on May 13 .
* The Irvine, California-based company is expected to report   a
63.0% increase in revenue to $7.794 million from $4.78 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for BIOLASE Inc is for a
loss of 5 cents per share. For the same quarter last year, the
company reported a loss of 11 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for BIOLASE Inc is
$2​, about 69% above​ its last closing price of $0.62. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.04       -0.04      -0.07     Missed  -90.9
 Sep. 30 2020  -0.05       -0.05      -0.05     Met     6.2
 Jun. 30 2020  -0.17       -0.17      -0.12     Beat    29.4​
 Mar. 31 2020  -0.14       -0.17      -0.11     Beat    34
 Dec.          ​           -0.05      -0.05     Met     0​
 31​ 2019​                                              
 Sep. 30 2019  -0.16       -0.14      -0.12     Beat    12.2​
 Jun. 30 2019  -0.12       -0.12      -0.13     Missed  -5.4
 Mar. 31 2019  -0.20       -0.18      -0.15     Beat    18.2
 This summary was machine generated May 11 at 20:34 GMT.  All
figures in US dollars unless otherwise stated